← Back to Search

Exercise Rehabilitation for Cancer

N/A
Recruiting
Led By Alice S. Ryan, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
History of treatment with either thoracotomy procedure or neurotoxic chemotherapy or both
Age 60-80 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, after 6 weeks control, and after 6 week intervention
Awards & highlights

Study Summary

This trial examines whether or not exercise can help reduce neuropathic pain in Veterans with lung cancer, in hopes that it will be a more effective (and less addictive) treatment than opioids.

Who is the study for?
This trial is for Veteran cancer survivors aged 60-80 with a history of lung cancer treatment, either surgery or chemotherapy. They must be able to walk on a treadmill, have moderate functional ability (Karnofsky >70), and experience neuropathic pain (Pain Scale score >1). Those with stage IV cancer, life expectancy under 6 months, or conditions preventing exercise can't join.Check my eligibility
What is being tested?
The study is testing if exercise rehabilitation can help reduce chronic neuropathic pain in Veterans who survived lung cancer compared to those who don't receive this intervention. It aims to find an alternative to opioid treatments by improving care through physical activity.See study design
What are the potential side effects?
While the trial doesn't involve drugs, exercising may cause muscle soreness, fatigue, and increase the risk of falls or injuries in participants. The severity will vary based on individual health status and adherence to safety protocols.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had surgery on my chest or chemotherapy that affects the nerves.
Select...
I am between 60 and 80 years old.
Select...
I have been diagnosed with lung cancer.
Select...
I am able to care for myself and perform normal activities with minimal assistance.
Select...
I can walk on a treadmill.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, after 6 weeks control, and after 6 week intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, after 6 weeks control, and after 6 week intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Visual Analog Scale Change
Secondary outcome measures
Fitness Change
Patient-Reported Outcomes Measurement System Neuropathic Pain Quality (PROMIS-PQ Neuro) Change
Strength Change

Side effects data

From 2012 Phase 4 trial • 200 Patients • NCT01342510
30%
Pain with injection of propofol
100%
80%
60%
40%
20%
0%
Study treatment Arm
Lidocaine/Magnesium
Control
Lidocaine
Magnesium

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ControlExperimental Treatment1 Intervention
Participants maintain their current activity level.
Group II: Exercise RehabilitationActive Control1 Intervention
Participants will exercise 2x/week at training facilities and at home one day a week.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,383 Total Patients Enrolled
Baltimore VA Medical CenterFED
32 Previous Clinical Trials
3,075 Total Patients Enrolled
Alice S. Ryan, PhDPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
6 Previous Clinical Trials
711 Total Patients Enrolled

Media Library

Exercise Rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT03621813 — N/A
Cancer Research Study Groups: Control, Exercise Rehabilitation
Cancer Clinical Trial 2023: Exercise Rehabilitation Highlights & Side Effects. Trial Name: NCT03621813 — N/A
Exercise Rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03621813 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for volunteers in this experiment?

"This trial is currently recruiting patients, as evidenced on clinicaltrials.gov. The medical study was posted back in August 19th 2019 and the most recent edit occurred January 6th 2022."

Answered by AI

Am I a suitable participant for this clinical trial?

"This medical investigation requires 50 elderly individuals (age 60-80) with existing malignancies. Furthermore, the prospective patients must have been treated 6 months ago or more via thoracotomy/chemotherapy and be capable of walking a treadmill. Additionally, they need to score above 1 on the Neuropathic Pain Scale for admission into this trial."

Answered by AI

Does this medical experiment consider applicants aged 85 or less?

"This medical trial is only looking for participants aged 60 to 80. There are 62 studies that accept applicants younger than 18 and 432 trials open to seniors over the age of 65."

Answered by AI

What is the aggregate enrollment of this medical experiment?

"Affirmative. Clinicaltrials.gov reveals that this clinical experiment has been actively recruiting since August 19th 2019, with the latest update occurring on January 6th 2022. 50 individuals are necessary to fulfill recruitment requirements at a single medical centre."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Exercise Rehabilitation in Veteran Cancer Survivors
2019. "Exercise Rehabilitation in Veteran Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03621813.
~2 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top